New anticancer drugs from marine cyanobacteria

Patrizia Russo; Alfredo Cesario

doi:10.2174/138945012802009035

New anticancer drugs from marine cyanobacteria

Patrizia Russo, Alfredo Cesario

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Abstract

Marine Cyanobacteria have raised growing attention as sources of bioactive "secondary metabolites" that originate from mixed biosynthetic pathways. Some of these molecules exhibit antitumour activities with unique mechanism of action. This mini-review focuses specifically on new molecules that may act as leads for novel drug development.

Original language	English
Pages (from-to)	1048-1053
Number of pages	6
Journal	Current Drug Targets
Volume	13
Issue number	8
DOIs	https://doi.org/10.2174/138945012802009035
Publication status	Published - Jul 2012

Keywords

Apratoxins
Bisebromoamide
Coibamide
Largazole
Lyngbya
Symploca

ASJC Scopus subject areas

Drug Discovery
Pharmacology
Clinical Biochemistry
Molecular Medicine

Access to Document

10.2174/138945012802009035

Cite this

@article{c799d3b11c0d4ef899200e9fd880993c,

title = "New anticancer drugs from marine cyanobacteria",

abstract = "Marine Cyanobacteria have raised growing attention as sources of bioactive {"}secondary metabolites{"} that originate from mixed biosynthetic pathways. Some of these molecules exhibit antitumour activities with unique mechanism of action. This mini-review focuses specifically on new molecules that may act as leads for novel drug development.",

keywords = "Apratoxins, Bisebromoamide, Coibamide, Largazole, Lyngbya, Symploca",

author = "Patrizia Russo and Alfredo Cesario",

year = "2012",

month = jul,

doi = "10.2174/138945012802009035",

language = "English",

volume = "13",

pages = "1048--1053",

journal = "Current Drug Targets",

issn = "1389-4501",

publisher = "Bentham Science Publishers B.V.",

number = "8",

}

TY - JOUR

T1 - New anticancer drugs from marine cyanobacteria

AU - Russo, Patrizia

AU - Cesario, Alfredo

PY - 2012/7

Y1 - 2012/7

N2 - Marine Cyanobacteria have raised growing attention as sources of bioactive "secondary metabolites" that originate from mixed biosynthetic pathways. Some of these molecules exhibit antitumour activities with unique mechanism of action. This mini-review focuses specifically on new molecules that may act as leads for novel drug development.

AB - Marine Cyanobacteria have raised growing attention as sources of bioactive "secondary metabolites" that originate from mixed biosynthetic pathways. Some of these molecules exhibit antitumour activities with unique mechanism of action. This mini-review focuses specifically on new molecules that may act as leads for novel drug development.

KW - Apratoxins

KW - Bisebromoamide

KW - Coibamide

KW - Largazole

KW - Lyngbya

KW - Symploca

UR - http://www.scopus.com/inward/record.url?scp=84863545536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863545536&partnerID=8YFLogxK

U2 - 10.2174/138945012802009035

DO - 10.2174/138945012802009035

M3 - Article

C2 - 22594472

AN - SCOPUS:84863545536

VL - 13

SP - 1048

EP - 1053

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 8

ER -

New anticancer drugs from marine cyanobacteria

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this